These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2408675)

  • 41. In vivo metabolism of proapolipoprotein A-I in Tangier disease.
    Bojanovski D; Gregg RE; Zech LA; Meng MS; Bishop C; Ronan R; Brewer HB
    J Clin Invest; 1987 Dec; 80(6):1742-7. PubMed ID: 3119665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of "A"-esterase activity in the serum of a patient with Tangier disease.
    Mackness MI; Peuchant E; Dumon MF; Walker CH; Clerc M
    Clin Biochem; 1989 Dec; 22(6):475-8. PubMed ID: 2558814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial hypoalphalipoproteinemia: definition of two groups based on plasma triglyceride levels.
    Edelstein C; Fredenrich CL; Scanu AM
    Trans Assoc Am Physicians; 1989; 102():148-57. PubMed ID: 2638523
    [No Abstract]   [Full Text] [Related]  

  • 44. Monoclonal antibodies to human apolipoprotein A-I: characterization and application as structural probes for apolipoprotein A-I and high density lipoprotein.
    Petit E; Ayrault-Jarrier M; Pastier D; Robin H; Polonovski J; Aragon I; Hervaud E; Pau B
    Biochim Biophys Acta; 1987 Jun; 919(3):287-96. PubMed ID: 2439127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human proapolipoprotein A-I: development of an antibody to the propeptide as a probe of apolipoprotein A-I biosynthesis and processing.
    Hospattankar AV; Fairwell T; Appella E; Meng M; Brewer HB
    Biochem Biophys Res Commun; 1987 Nov; 149(1):289-96. PubMed ID: 3120726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial high-density lipoprotein deficiency (Tangier disease): the third Italian case.
    Bracco G; Dotti G; Levis F; David E; Saracco G; Rizzetto M; Verme G
    J Inherit Metab Dis; 1988; 11 Suppl 2():155-7. PubMed ID: 3141697
    [No Abstract]   [Full Text] [Related]  

  • 47. [Abnormal lipid metabolism in Tangier disease].
    Yamada N; Murase T
    Nihon Rinsho; 1983 Aug; 41(8):1817-23. PubMed ID: 6632290
    [No Abstract]   [Full Text] [Related]  

  • 48. Standardization of an enzymometric assay for apolipoprotein A-I by using mixtures of monoclonal antibodies).
    Betard C; Vu-Dac N; Mezdour H; Nestruck AC; Leroy A; Fruchart JC
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):893-9. PubMed ID: 3127531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformation of apolipoprotein B-100 in the low density lipoproteins of tangier disease. Identification of localized conformational response to triglyceride content.
    Kunitake ST; Young SG; Chen GC; Pullinger CR; Zhu S; Pease RJ; Scott J; Hass P; Schilling J; Kane JP
    J Biol Chem; 1990 Dec; 265(34):20739-46. PubMed ID: 1701170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bile lipids, platelet aggregability and pro-ApoAI processing in 2 cases of Tangier disease.
    Catapano AL; Giudici G; Roma P; Vergani CG
    Monogr Atheroscler; 1986; 14():154-8. PubMed ID: 3736556
    [No Abstract]   [Full Text] [Related]  

  • 51. Tangier disease: one explanation of lipid storage.
    Herbert PN; Forte T; Heinen RJ; Fredrickson DS
    N Engl J Med; 1978 Sep; 299(10):519-21. PubMed ID: 210378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoalpha-hyperbeta-lipoproteinemia in a patient with coronary artery disease and occlusive peripheral arterial disease.
    Toth L; Koenig W
    Atherosclerosis; 1982 Mar; 42(1):121-4. PubMed ID: 7082413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-I.
    Leroy A; Olivier P; Vu-Dac N; Fruchart JC
    Clin Chim Acta; 1989 Jan; 179(1):85-95. PubMed ID: 2493349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.
    Hogle DM; Smith RS; Curtiss LK
    J Lipid Res; 1988 Sep; 29(9):1221-9. PubMed ID: 3141545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.
    Glickman RM; Green PH; Lees RS; Tall A
    N Engl J Med; 1978 Dec; 299(26):1424-7. PubMed ID: 213720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease).
    Vergani CG; Plancher AC; Zuin M; Cattaneo M; Tramaloni C; Maccari S; Roma P; Catapano AL
    Eur J Clin Invest; 1984 Feb; 14(1):49-54. PubMed ID: 6421598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial hypocholesterolemia and HDL deficiency.
    Dumon MF; Freneix-Clerc M; Maviel MJ; Clerc M
    Adv Exp Med Biol; 1991; 285():161-71. PubMed ID: 1858547
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum lipoprotein analysis of a patient with Tangier disease].
    Takizawa A; Komoda T; Sakagishi Y; Okano K; Doi Y; Tanaka A; Oguro T
    Rinsho Byori; 1989 Mar; 37(3):285-90. PubMed ID: 2746918
    [No Abstract]   [Full Text] [Related]  

  • 59. Familial hypo-alpha-lipoproteinemia.
    Vergani C; Bettale G
    Clin Chim Acta; 1981 Jul; 114(1):45-52. PubMed ID: 7249374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corneal opacification and familial disorders affecting plasma high-density lipoprotein.
    Winder AF; Borysiewicz LK
    Birth Defects Orig Artic Ser; 1982; 18(6):433-40. PubMed ID: 7171769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.